| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Eduardo Vital de Carvalho, Michele Emy Hukuda, Renata Escorcio, Mariana Callil Voos, Fátima Aparecida Caroman. Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study. Physiotherapy research international : the journal for researchers and clinicians in physical therapy. vol 20. issue 3. 2016-06-09. PMID:25521365. |
the progression of duchenne muscular dystrophy (dmd) results in the emergence of multiple and varied synergies to compensate muscle weakness and to deal with the demands of the functional tasks (e.g. |
2016-06-09 |
2023-08-13 |
Not clear |
| Martin Steinberger, Michael Föller, Silke Vogelgesang, Mirjam Krautwald, Martin Landsberger, Claudia K Winkler, Joachim Kasch, Ernst-Martin Füchtbauer, Dietmar Kuhl, Jakob Voelkl, Florian Lang, Heinrich Brinkmeie. Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle. Pflugers Archiv : European journal of physiology. vol 467. issue 9. 2016-05-18. PMID:25394886. |
duchenne muscular dystrophy (dmd) is a human genetic disease characterized by fibrosis and severe muscle weakness. |
2016-05-18 |
2023-08-13 |
mouse |
| Ngoc B Lu-Nguyen, Susan A Jarmin, Amer F Saleh, Linda Popplewell, Michael J Gait, George Dickso. Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice. Molecular therapy : the journal of the American Society of Gene Therapy. vol 23. issue 8. 2016-05-10. PMID:25959011. |
the fatal x-linked duchenne muscular dystrophy (dmd), characterized by progressive muscle wasting and muscle weakness, is caused by mutations within the dmd gene. |
2016-05-10 |
2023-08-13 |
mouse |
| Jihee Sohn, Aiping Lu, Ying Tang, Bing Wang, Johnny Huar. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice. Human molecular genetics. vol 24. issue 13. 2016-04-28. PMID:25859011. |
results from this study suggest that approaches to alleviate muscle weakness and wasting in dmd patients should not only target the myogenic mpcs but should also attempt to prevent the activation of the nmmscs. |
2016-04-28 |
2023-08-13 |
mouse |
| Takeshi Tsuda, Kristi Fitzgerald, Mena Scavena, Samuel Gidding, Mary O Cox, Harold Marks, Kevin M Flanigan, Steven A Moor. Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27. Journal of human genetics. vol 60. issue 3. 2016-04-01. PMID:25537791. |
in addition, their 7-year-old nephew with delayed gross motor development, mild proximal muscle weakness and markedly elevated serum creatine kinase level (>13 000 iu l(-1)) at 16 months was recently demonstrated to have the familial dmd mutation. |
2016-04-01 |
2023-08-13 |
Not clear |
| Craig A Canapari, Nick Barrowman, Lynda Hoey, Scott W Walker, Elise Townsend, Brian S Tseng, Sherri L Kat. Truncal fat distribution correlates with decreased vital capacity in Duchenne muscular dystrophy. Pediatric pulmonology. vol 50. issue 1. 2016-03-31. PMID:24644236. |
duchenne muscular dystrophy (dmd) is an x-linked recessive disorder associated with progressive muscle weakness and respiratory failure. |
2016-03-31 |
2023-08-12 |
human |
| Ulrike Schara, Melanie Busse, Dagmar Timmann, Marcus Gerwi. Cerebellar-dependent associative learning is preserved in Duchenne muscular dystrophy: a study using delay eyeblink conditioning. PloS one. vol 10. issue 5. 2016-02-04. PMID:25973604. |
besides progressive muscle weakness cognitive deficits have been reported in patients with duchenne muscular dystrophy (dmd). |
2016-02-04 |
2023-08-13 |
Not clear |
| David I Stapleton, Xianzhong Lau, Marcelo Flores, Jennifer Trieu, Stefan M Gehrig, Annabel Chee, Timur Naim, Gordon S Lynch, René Koopma. Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice. PloS one. vol 9. issue 3. 2016-01-29. PMID:24626262. |
duchenne muscular dystrophy (dmd) is a severe, genetic muscle wasting disorder characterised by progressive muscle weakness. |
2016-01-29 |
2023-08-12 |
mouse |
| Janneke C van den Bergen, Monika Hiller, Stefan Böhringer, Linda Vijfhuizen, Hendrika B Ginjaar, Amina Chaouch, Kate Bushby, Volker Straub, Mariacristina Scoto, Sebahattin Cirak, Véronique Humbertclaude, Mireille Claustres, Chiara Scotton, Chiara Passarelli, Hanns Lochmüller, Francesco Muntoni, Sylvie Tuffery-Giraud, Alessandra Ferlini, Annemieke M Aartsma-Rus, Jan J G M Verschuuren, Peter Ac 't Hoen, Pietro Spital. Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants. Journal of neurology, neurosurgery, and psychiatry. vol 86. issue 10. 2015-12-14. PMID:25476005. |
duchenne muscular dystrophy (dmd) is characterised by progressive muscle weakness. |
2015-12-14 |
2023-08-13 |
Not clear |
| Fumi Takeuchi, Hirofumi Komak. [Update of steroid therapy for Duchenne muscular dystrophy]. No to hattatsu = Brain and development. vol 47. issue 4. 2015-11-30. PMID:26353447. |
however, steroids are currently the only medication that has been objectively confirmed to have an effect on muscle weakness in dmd patients. |
2015-11-30 |
2023-08-13 |
Not clear |
| Thais Borges Lessa, Dilayla Kelly de Abreu, Márcio Nogueira Rodrigues, Marina Pandolphi Brólio, Maria Angélica Miglino, Carlos Eduardo Ambrósi. Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle. Microscopy research and technique. vol 77. issue 11. 2015-10-19. PMID:25081087. |
duchenne muscular dystrophy (dmd) is a genetic disease, characterized by atrophy and muscle weakness. |
2015-10-19 |
2023-08-13 |
Not clear |
| Hirohito Ishii, Kunihide Nakamura, Hiroyuki Nagahama, Masakazu Matsuyama, Jouji Endo, Masanori Nishimur. [Mitral valve replacement for a manifesting carrier of duchenne muscular dystrophy]. Kyobu geka. The Japanese journal of thoracic surgery. vol 68. issue 2. 2015-09-29. PMID:25743350. |
here we report a case of a manifesting carrier of dmd with skeletal muscle weakness and cardiac abnormalities such as deterioration of cardiac function and left ventricular dilatation, who successfully underwent cardiac surgery. |
2015-09-29 |
2023-08-13 |
Not clear |
| DeWayne Townsen. Diastolic dysfunction precedes hypoxia-induced mortality in dystrophic mice. Physiological reports. vol 3. issue 8. 2015-08-28. PMID:26311833. |
duchenne muscular dystrophy (dmd) is a progressive striated muscle disease that is characterized by skeletal muscle weakness with progressive respiratory and cardiac failure. |
2015-08-28 |
2023-08-13 |
mouse |
| Francesca Iodice, Giuseppina Testa, Marco Averardi, Gianluca Brancaccio, Antonio Amodeo, Paola Cog. Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned. Neuromuscular disorders : NMD. vol 25. issue 1. 2015-08-21. PMID:25444433. |
duchenne muscular dystrophy (dmd) is an x-linked recessive disorder, characterized by progressive skeletal muscle weakness, loss of ambulation, and death secondary to cardiac or respiratory failure. |
2015-08-21 |
2023-08-13 |
Not clear |
| Jason L Buckner, Sasigarn A Bowden, John D Maha. Optimizing Bone Health in Duchenne Muscular Dystrophy. International journal of endocrinology. vol 2015. 2015-06-30. PMID:26124831. |
duchenne muscular dystrophy (dmd) is an x-linked recessive disorder characterized by progressive muscle weakness, with eventual loss of ambulation and premature death. |
2015-06-30 |
2023-08-13 |
Not clear |
| Aurélie Goyenvalle, Graziella Griffith, Arran Babbs, Samir El Andaloussi, Kariem Ezzat, Aurélie Avril, Branislav Dugovic, Rémi Chaussenot, Arnaud Ferry, Thomas Voit, Helge Amthor, Claudia Bühr, Stefan Schürch, Matthew J A Wood, Kay E Davies, Cyrille Vaillend, Christian Leumann, Luis Garci. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nature medicine. vol 21. issue 3. 2015-05-01. PMID:25642938. |
we demonstrate these properties in two mouse models of duchenne muscular dystrophy (dmd), a neurogenetic disease typically caused by frame-shifting deletions or nonsense mutations in the gene encoding dystrophin and characterized by progressive muscle weakness, cardiomyopathy, respiratory failure and neurocognitive impairment. |
2015-05-01 |
2023-08-13 |
mouse |
| Aiping Lu, Minakshi Poddar, Ying Tang, Jonathan D Proto, Jihee Sohn, Xiaodong Mu, Nicholas Oyster, Bing Wang, Johnny Huar. Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice. Human molecular genetics. vol 23. issue 18. 2015-04-23. PMID:24781208. |
duchenne muscular dystrophy (dmd) patients lack dystrophin from birth; however, muscle weakness becomes apparent only at 3-5 years of age, which happens to coincide with the depletion of the muscle progenitor cell (mpc) pools. |
2015-04-23 |
2023-08-13 |
mouse |
| Chang-Yong Tsa. Muscle disease. Pediatrics in review. vol 35. issue 2. 2015-04-02. PMID:24488829. |
patients with dmd present with progressive symmetrical limb-girdle muscle weakness and become wheelchair dependent after age 12 years. |
2015-04-02 |
2023-08-12 |
Not clear |
| Davi A G Mázala, Robert W Grange, Eva R Chi. The role of proteases in excitation-contraction coupling failure in muscular dystrophy. American journal of physiology. Cell physiology. vol 308. issue 1. 2015-03-04. PMID:25298424. |
these data further suggest that acute protease inhibition may be useful in reducing muscle weakness in dmd. |
2015-03-04 |
2023-08-13 |
mouse |
| H M Jenkins, A Stocki, D Kriellaars, H Pasterkam. Breath stacking in children with neuromuscular disorders. Pediatric pulmonology. vol 49. issue 6. 2015-01-20. PMID:23956183. |
compared to ibs, vbs achieved similar volumes in the six subjects with dmd but sbs was more successful in those with greatest muscle weakness. |
2015-01-20 |
2023-08-12 |
human |